How to Prevent or Handle Protocol Deviations and Violations to be GCP and Regulatory Compliant?

July 28, 2011 - PRLog -- Why Should You Attend:
Following exactly the signed and approved (IRB + PI) Protocol to the letter is the goal and mandate of all clinical research. This, in fact, is included on the FDA Form 1572.

This Webinar deals with what happens, and under what circumstances, when the protocol is not followed (PNF) and why this is of particular significance. Covered, will be how a protocol deviation with the least significant effect where there is no substantive effect on the risks to research participants, no substantial effect of the value or integrity of the data, and did not result from willful or knowing misconduct on the part of the investigator is handled.

Areas Covered in the Seminar:

- The Primacy of the study Protocol.
- What are Protocol “Deviation” and other terms / categories.
- The many cause of protocol deviations.
- The Regulatory requirements for handling protocol deviations and violations.
- The importance of documentation of protocol deviations as well as violations.
- How to define and handle instances of PNF.
- What is the reason different IRBs define deviations and violations differently.
- What is the basis of the difference between a “Deviation” and a “Violation”.

Note : Add another webinar to your shopping cart and get 20% off on its price.

For More Details:
http://complianceonline.com/ecommerce/control/trainingFoc...

# # #

Enhancing global compliance, creating a world where quality and compliance professionals, regulators, and government agencies come together to help the world comply with the intent and the spirit of laws, policies and mandates.